Dexcom’s new CGM for non-insulin users.

What started as a lifesaving device for insulin users is continuing to become more accessible. “Dexcom is unveiling Stelo as competitor Abbott has launched a direct-to-consumer program using a CGM for people without diabetes. The program, called Lingo, is currently available in the U.K., but Abbott has said it planned to file in the U.S. by the end of 2023.” ~ learn more